Comparative efficacy and safety of pharmacological treatments for lower-risk myelodysplastic syndromes: a Systematic Review and network meta-analysis - Quiz - MDSpire

Efficacy and Safety Comparison of Drug Therapies for Lower-Risk Myelodysplastic Syndromes: A Systematic Review and Network Meta-Analysis

By
Haixia Zhang
Jiaqiang Hu
Yaxi Jiang
Lihua Deng
Song Liu
June 16, 2026

Frontiers In Oncology

Share

Original Source(s)

Frontiers In Oncology

Comparative efficacy and safety of pharmacological treatments for lower-risk myelodysplastic syndromes: a Systematic Review and network meta-analysis

by Haixia Zhang, Jiaqiang Hu, Yaxi Jiang, Lihua Deng, Song Liu
June 16, 2026

Related Content

Frontiers In Immunology

Correction: γδ T cells in immunotherapies for B-cell malignancies

by Léa Rimailho, Carla Faria, Marcin Domagala, Camille Laurent, Christine Bezombes, Mary Poupot
August 17, 2026

Jmir Dermatology

Efficiency and Sustainability in the Skin Cancer Excision Pathway: Life Cycle Assessment and Process Map

Frontiers In Oncology

Editorial: Chimeric antigen receptor T cell therapies and bispecific antibodies in hematologic malignancies

by Yangmin Zhu
August 18, 2026